COMPARISON OF BOTULINUM TOXIN VS LATERAL SPHINCTEROTOMY FOR THE TREATMENT OF CHRONIC ANAL FISSURE

A KHAN; M ZARIN; . KHADEEJA

doi:10.54112/bcsrj.v2024i1.901

Authors

A KHAN Department of Surgery, Khyber Teaching Hospital Peshawar, Pakistan
M ZARIN Department of Surgery, Khyber Teaching Hospital Peshawar, Pakistan
. KHADEEJA Department of Surgery, Khyber Teaching Hospital Peshawar, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v2024i1.901

Keywords:

Chronic anal fissure, botulinum toxin, lateral sphincterotomy, symptom resolution, comparative study

Abstract

Chronic anal fissure is a distressing condition characterized by a tear or ulcer in the lining of the anal canal. Objectives: The primary aim of this study is to compare the effectiveness of botulinum toxin versus lateral sphincterotomy in the treatment of chronic anal fissures. Methods: This comparative study was conducted at Khyber Teaching Hospital, Peshawar, from 13th August 2023 to 3rd December 2023. Data were collected from 278 patients diagnosed with chronic anal fissure, retrospectively extracted from electronic medical records. A total of 268 patients were included in the analysis, with 134 patients in each treatment group. Baseline characteristics, including age, gender distribution, and duration of symptoms, were recorded for both groups. Results: The mean age of patients in the botulinum toxin group (Group A) was 42.5 ± 8.3 years, and in the lateral sphincterotomy group (Group B) it was 45.2 ± 7.9 years. There were 52% males in Group A and 48% in Group B. The mean duration of symptoms was 10.3 ± 4.7 months in Group A and 11.8 ± 5.2 months in Group B. Symptom resolution was significantly higher in the lateral sphincterotomy group (92%) compared to the botulinum toxin injection group (78%). Conclusion: Lateral sphincterotomy demonstrates superior efficacy in promoting symptom resolution and fissure healing compared to botulinum toxin injection, albeit with a higher risk of complications.

Downloads

Download data is not yet available.

References

Chen H-L, Woo X-B, Wang H-S, Lin Y-J, Luo H-X, Chen Y-H, et al. Botulinum toxin injection versus lateral internal sphincterotomy for chronic anal fissure: a meta-analysis of randomized control trials. Techniques in coloproctology. 2014;18:693-8.

Khryukin RY, Kostarev I, Arslanbekova K, Nagudov M, Zharkov E. BOTULINUM TOXIN TYPE A AND LATERAL SUBCUTANEOUS SPHINCTEROTOMY FOR CHRONIC ANAL FISSURE WITH THE SPHINCTER SPASM. WHAT TO CHOOSE?(systematic literature review and meta-analysis). Koloproktologia. 2020;19(2):113-28.

Alyanak A, Gulen M, Ege B. Comparison of botulinum toxin (BoNT) injection and lateral internal sphincterotomy (redo-LIS) for recurrent anal fissure treatment. Frontiers in Surgery. 2022;9:988082.

De Robles MS, Young CJ. Real world outcomes of lateral internal sphincterotomy vs botulinum toxin for the management of chronic anal fissures. Asian Journal of Surgery. 2022;45(1):184-8.

Maurice PN, Amin ARM, Habeeb T, Orban YA. Comparing Outcomes of Lateral Internal Sphincterotomy, Botulinum Toxin Injection and Laser Therapy in the Management of Chronic Anal Fissure. The Egyptian Journal of Hospital Medicine. 2023;90(2):2482-7.

Ahmed U, Zulqarnan M, Arshad A, Azad MH, Dawach A, Panhwar DM, et al. TREATING CHRONIC ANAL FISSURE: A NON-RANDOMIZED CONTROLLED TRIAL COMPARING BOTULINUM TOXIN INJECTION AND LATERAL INTERNAL SPHINCTEROTOMY. Journal of Population Therapeutics and Clinical Pharmacology. 2023;30(19):801-6.

Chiarello MM, Cariati M, Brisinda G. Botulinum toxin versus other therapies for treatment of chronic anal fissure. coloproctology. 2020;42(6):457-63.

Ravindra C. Comparative study of Botulinum Toxin Injection and Lateral Internal Sphincterotomy in the Treatment of Chronic Anal Fissure: Madras Medical College, Chennai; 2020.

Mohamed IAE-F, Shalamesh MI, Badawy ASM. Comparative Study Between Lateral Internal Sphincterotomy vs. Botulinum Toxin Injection In The Treatment Of Chronic Anal Fissure. Al-Azhar International Medical Journal. 2023;4(10):41.

Boland P, Kelly M, Donlon N, Bolger J, Larkin J, Mehigan B, et al. Management options for chronic anal fissure: a systematic review of randomised controlled trials. International journal of colorectal disease. 2020;35:1807-15.

Brisinda G, Fico V, Tropeano G, Altieri G, Chiarello MM. Effectiveness and safety of botulinum toxin injection in the treatment of recurrent anal fissure following lateral internal sphincterotomy: cohort study. BJS open. 2024;8(1):zrad156.

Roelandt P, Coremans G, Wyndaele J. Injection of botulinum toxin significantly increases efficiency of fissurectomy in the treatment of chronic anal fissures. International Journal of Colorectal Disease. 2022:1-4.

Goloktionov NA, Kashnikov VN, Tkalich OV, Ponomarenko AA, Khryukin RY, Kostarev IV, et al. Comparison of different doses botulinum toxin type A efficacy in chronic anal fissure treatment. Experimental and Applied Biomedical Research (EABR). 2022;23(1):13-28.

Acar T, Acar N, Güngör F, Kamer E, Genç H, Atahan K, et al. Comparative efficacy of medical treatment versus surgical sphincterotomy in the treatment of chronic anal fissure. Nigerian journal of clinical practice. 2020;23(4):539-44.

Xu H, Yang W, Mei Z. Botulinum toxin as a promising surgical strategy for chronic anal fissure: do the dose and injection site matter? Comparison of doses and injection sites of botulinum toxin for chronic anal fissure: A systematic review and network meta-analysis of randomized controlled trials. International Journal of Surgery. 2023;109(3):495-6.